Abstract:Background Cellular response to pharmacological action of drugs is significant for drug development. Traditional detection method for cellular response to drugs normally rely on cell proliferation assay and metabolomics examination. In principle, these analytical methods often required cell labeling, invasion analysis, and hours of co-culture with drugs, which are relatively complex and time-consuming. Moreover, these methods can only indicate the drug effectiveness on cell colony rather than single cells. Thus, to meet the requirements of personal precision medicine, the development of drug response analysis on the high resolution of single cell is demanded. Results To provide precise result for drug response on single-cell level, a microfluidic platform coupled with the label-free hyperspectral imaging was developed. With the help of horizontal single-cell trapping sieves, hundreds of single cells were trapped independently in microfluidic channels for the purposes of real-time drug delivery and single-cell hyperspectral image recording. To significantly identify the cellular hyperspectral change after drug stimulation, the differenced single-cell spectrum was proposed. Compared with the deep learning classification method based on hyperspectral images, an optimal performance can be achieved by the classification strategy based on differenced spectra. And the cellular response to different reagents, for example, K + , Epidermal Growth Factor (EGF), and Gefitinib at different concentrations can be accurately characterized by the differenced single-cell spectra analysis. Significance and novelty The high-throughput, rapid analysis of cellular response to drugs at the single-cell level can be accurately performed by our platform. After systematically analyzing the materials and the structures of the single-cell microfluidic chip, the optimal single-cell trapping method was proposed to contribute to the further application of hyperspectral imaging on microfluidic single-cell analysis. And the hyperspectral characterization of single-cell with cancer drug stimulation proved the application potential of our method in personal cancer medication.

Single-Cell Diagnosis of Cancer Drug Resistance through the Differential Endocytosis of Nanoparticles between Drug-Resistant and Drug-Sensitive Cancer Cells

A multiparametric fluorescent visualization approach for detecting drug resistance in living cancer cells

Circumventing Drug Resistance Pathways with a Nanoparticle-Based Photodynamic Method

In Situ Drug-Receptor Binding Kinetics in Single Cells: a Quantitative Label-Free Study of Anti-Tumor Drug Resistance

In Vitro Anticancer Drug Sensitivity Sensing Through Single-Cell Raman Spectroscopy

Single Living Cell Analysis Nanoplatform for High-Throughput Interrogation of Gene Mutation and Cellular Behavior

Measuring Drug Response with Single-Cell Growth Rate Quantification

The reversal of chemotherapy-induced multidrug resistance by nanomedicine for cancer therapy

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance

Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches

Phenotype-related drug sensitivity analysis of single CTCs for medicine evaluation

Emerging Nano-Based Strategies Against Drug Resistance in Tumor Chemotherapy

A versatile dilution-treatment-detection microfluidic chip platform for rapid In vitro lung cancer drug combination sensitivity evaluation

Subcellular-Scale Drug Transport Via Ultrasound-Degradable Mesoporous Nanosilicon to Bypass Cancer Drug Resistance.

Nanoplatform to Investigate Tumor-Initiating Cancer Stem Cells: Breaking the Diagnostic Barrier

Anti-Cancer Drug Sensitivity Assay with Quantitative Heterogeneity Testing Using Single-Cell Raman Spectroscopy

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Progress in Research of Nanotherapeutics for Overcoming Multidrug Resistance in Cancer

Analysis of cellular response to drugs with a microfluidic single-cell platform based on hyperspectral imaging

Nano-drug delivery system for the treatment of multidrug-resistant breast cancer: Current status and future perspectives